Daily activities and leisure interests of repiratory failure patients in ANTADIR Network Source: Eur Respir J 2001; 18: Suppl. 33, 488s Year: 2001
Serving researchers, the impact factor and other conflicts of interest Source: Eur Respir J 2005; 25: 3-5 Year: 2005
Chemopreventive effect of long-term use of low-dose aspirin on lung cancer risk : A nationwide study considering competing risk Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough Source: Eur Respir J 2015; 46: 607-614 Year: 2015
Reply to “COVID-19 prediction models should adhere to methodological and reporting standards” Source: Eur Respir J, 56 (3) 2002918; 10.1183/13993003.02918-2020 Year: 2020
COVID-19 prediction models should adhere to methodological and reporting standards Source: Eur Respir J, 56 (3) 2002643; 10.1183/13993003.02643-2020 Year: 2020
Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns Source: Eur Respir J 2016; 48: 1523-1524 Year: 2016
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns Source: Eur Respir J 2016; 48: 1524-1526 Year: 2016
Use of health outcomes questionnaires: authorship and copyright issues. Examples in the respiratory field Source: Eur Respir J 2007; 30: Suppl. 51, 196s Year: 2007
Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017 Year: 2018
E-patient reported outcomes: Can you have reliance on compliance? Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011
Health beliefs, behaviour and goals of professional health carers and adolescents with asthma: exploring and matching perspectives for improving concordance with self-management Source: Eur Respir J 2004; 24: Suppl. 48, 430s Year: 2004
Describing what evidence and outcomes to use in guidelines Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008
Universal use of face masks for success against COVID-19: evidence and implications for prevention policies Source: Eur Respir J, 55 (6) 2001260; 10.1183/13993003.01260-2020 Year: 2020
Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies? Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019
Patients‘ knowledge and perception of therapy, and declared behaviours toward inhaled corticosteroids – preliminary results from a community pharmacists study Source: Annual Congress 2008 - COPD epidemiology Year: 2008
The issues and the controversies: are we really ready for on-demand use of ICS? Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use? Year: 2013
Oral appliances: from theory to practice. Recent data regarding compliance, efficacy and side-effects Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005